Table 1 Characteristics of scleroderma patients participating in the study at baseline
| Variables | |
|---|---|
| Demographic/anthropometric data | |
| Age (years) | 51 (40–63) |
| BMI (kg/m2) | 26.4 (24–31) |
| Clinical characteristics | |
| Limited cutaneous scleroderma (n, %) | 7 (58.3) |
| Diffuse cutaneous scleroderma (n, %) | 5 (41.7) |
| ILD (n, %) | 12 (100%) |
| PH (n, %) | 3 (25%) |
| Gastrointestinal symptoms (n, %) | 6 (50%) |
| Renal crisis (n, %) | 1 (8.3%) |
| Serology | |
| Anti-TOPO I positivity (n, %) | 8 (66.7%) |
| Anti-RNAP III positivity (n, %) | 3 (25%) |
| Anti-centromere positivity (n, %) | 1 (8.3%) |